PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10391681-1	1999	Fas ligation in the presence of cycloheximide induced Jun N-terminal kinase 1 (JNK1) and JNK2 phosphorylation, caspase activation and cell death in the IL-3-dependent cell line BAF3.	Cycloheximide	32-45	interleukin 3	Homo sapiens	152-156	
15459750-8	2004	Additionally, coincubation with cycloheximide blocked the mitotic effects of GM-CSF or IL-3, allowing only the apoptotic responses of TNF to persist.	Cycloheximide	32-45	interleukin 3	Homo sapiens	87-91	
12554354-5	2003	The IL-3-induced expression of CD13 was decreased in the presence of the protein-synthesis inhibitor cycloheximide (-8.8%).	Cycloheximide	101-114	interleukin 3	Homo sapiens	4-8	
1371965-10	1992	Cycloheximide completely inhibited the IL-3-induced expression of CD25, indicating the necessity for protein synthesis, and although most of the CD25+ cells were in G0/G1 phase, 25% of the cells were in S or G2M phase, indicating that receptor expression was not cell-cycle dependent.	Cycloheximide	0-13	interleukin 3	Homo sapiens	39-43	
8395533-0	1993	Interleukin-3 inhibits cycloheximide induction of C-jun mRNA in human monocytes: possible role for a serine/threonine phosphatase.	Cycloheximide	23-36	interleukin 3	Homo sapiens	0-13	
8395533-3	1993	The pluripotent colony stimulating factor interleukin-3 (IL-3) (10 ng/ml) is also a modest inducer of the c-jun gene in these cells; however, in combination with cycloheximide, IL-3 dramatically reduces the c-jun induction below levels induced by cycloheximide alone.	Cycloheximide	162-175	interleukin 3	Homo sapiens	42-55	
8395533-3	1993	The pluripotent colony stimulating factor interleukin-3 (IL-3) (10 ng/ml) is also a modest inducer of the c-jun gene in these cells; however, in combination with cycloheximide, IL-3 dramatically reduces the c-jun induction below levels induced by cycloheximide alone.	Cycloheximide	162-175	interleukin 3	Homo sapiens	57-61	
8395533-3	1993	The pluripotent colony stimulating factor interleukin-3 (IL-3) (10 ng/ml) is also a modest inducer of the c-jun gene in these cells; however, in combination with cycloheximide, IL-3 dramatically reduces the c-jun induction below levels induced by cycloheximide alone.	Cycloheximide	247-260	interleukin 3	Homo sapiens	42-55	
8395533-3	1993	The pluripotent colony stimulating factor interleukin-3 (IL-3) (10 ng/ml) is also a modest inducer of the c-jun gene in these cells; however, in combination with cycloheximide, IL-3 dramatically reduces the c-jun induction below levels induced by cycloheximide alone.	Cycloheximide	247-260	interleukin 3	Homo sapiens	57-61	
8395533-4	1993	This is a true inhibition and is not due to a change in temporal kinetics of induction because the suppression in the presence of IL-3 is observed at both 30 and 60 min after simultaneous addition of both IL-3 and cycloheximide.	Cycloheximide	214-227	interleukin 3	Homo sapiens	130-134	
8395533-5	1993	Preincubation of monocytes with 12.5 nM okadaic acid (a potent inhibitor of protein phosphatases 1 and 2A) and cycloheximide prior to addition of IL-3 restored the level of c-jun induction to that mediated by cycloheximide alone.	Cycloheximide	209-222	interleukin 3	Homo sapiens	146-150	
8395533-7	1993	These observations suggest that activation of protein serine/threonine phosphatase(s) underlies the ability of IL-3 to inhibit cycloheximide induction of c-jun in monocytes.	Cycloheximide	127-140	interleukin 3	Homo sapiens	111-115	
2049179-5	1991	The protein synthesis inhibitor, cycloheximide, enhances survival on IL3 removal, suggesting that death is an active process.	Cycloheximide	33-46	interleukin 3	Homo sapiens	69-72